A theranostic metallodrug modulates immunovascular crosstalk to combat immunosuppressive liver cancer.
Luo Y, Wang J, Xu L, Du Q, Fang N, Wu H, Liu F, Hu L, Xu J, Hou J, Zhong Y, Liu Y, Wang Z, Ran H, Guo D.
Luo Y, et al.
Acta Biomater. 2022 Dec;154:478-496. doi: 10.1016/j.actbio.2022.10.032. Epub 2022 Oct 21.
Acta Biomater. 2022.
PMID: 36280029